What's Happening
Tilray and other cannabis stocks surged after reports that Trump is preparing to reclassify cannabis, potentially opening medical research pathways and banking services for growers. The move would represent a significant regulatory shift for an industry long hampered by federal prohibition.
Market Impact
Reclassification would unlock institutional capital, banking access, and research funding for cannabis operators, dramatically improving unit economics. Tilray and peers could see valuation re-rating if the policy materializes, though execution risk remains high given political opposition.
Broader Implications
Cannabis reclassification would normalize a $100+ billion market and align U.S. policy with state-level legalization. This signals a broader shift toward deregulation under Trump, with implications for other restricted industries seeking federal approval.